X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (137) 137
index medicus (125) 125
urology & nephrology (115) 115
cancer (85) 85
male (75) 75
urology (65) 65
middle aged (59) 59
oncology (54) 54
kidney neoplasms - pathology (52) 52
female (51) 51
metastasis (50) 50
aged (49) 49
nephrectomy (49) 49
clinical medicine (45) 45
renal cell carcinoma (45) 45
klinisk medicin (44) 44
medical and health sciences (44) 44
medicin och hälsovetenskap (44) 44
sunitinib (44) 44
carcinoma, renal cell (43) 43
survival (42) 42
kidney neoplasms - surgery (39) 39
carcinoma, renal cell - drug therapy (38) 38
care and treatment (38) 38
urologi och njurmedicin (37) 37
urology and nephrology (37) 37
treatment outcome (36) 36
carcinoma, renal cell - surgery (35) 35
kidney neoplasms - drug therapy (34) 34
carcinoma (33) 33
carcinoma, renal cell - pathology (33) 33
interferon-alpha (30) 30
adult (29) 29
kidney cancer (29) 29
surgery (29) 29
antineoplastic agents - therapeutic use (26) 26
targeted therapy (25) 25
therapy (22) 22
carcinoma, renal cell - secondary (21) 21
carcinoma, renal cell - therapy (21) 21
cytoreductive nephrectomy (21) 21
kidney neoplasms - therapy (21) 21
neoplasm metastasis (21) 21
tumors (21) 21
prognosis (20) 20
analysis (19) 19
medicine & public health (19) 19
guidelines (18) 18
radical nephrectomy (18) 18
renal-cell carcinoma (18) 18
retrospective studies (18) 18
kidney neoplasms - mortality (17) 17
trial (17) 17
combined modality therapy (16) 16
immunotherapy (16) 16
molecular targeted therapy (16) 16
aged, 80 and over (15) 15
antineoplastic agents (15) 15
carcinoma, renal cell - mortality (15) 15
time factors (15) 15
sorafenib (14) 14
antimitotic agents (13) 13
cancer and oncology (13) 13
cancer och onkologi (13) 13
cell carcinoma (13) 13
disease-free survival (13) 13
follow-up (13) 13
nephrectomy - methods (13) 13
prospective studies (13) 13
renal cell cancer (13) 13
biopsy (12) 12
hematology, oncology and palliative medicine (12) 12
indoles - therapeutic use (12) 12
medical colleges (12) 12
neoplasm staging (12) 12
prostate cancer (12) 12
pyrroles - therapeutic use (12) 12
radiology, nuclear medicine & medical imaging (12) 12
survival rate (12) 12
bladder cancer (11) 11
diagnosis (11) 11
everolimus (11) 11
health aspects (11) 11
management (11) 11
risk factors (11) 11
animals (10) 10
chemotherapy (10) 10
dissection (10) 10
efficacy (10) 10
experience (10) 10
kidney neoplasms (10) 10
nephrology (10) 10
patient selection (10) 10
progression (10) 10
abridged index medicus (9) 9
chemotherapy, adjuvant (9) 9
clinical trials (9) 9
disease progression (9) 9
medical research (9) 9
metastasectomy (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet Oncology, ISSN 1470-2045, 12/2019
Journal Article
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 10/2018, Volume 15, Issue 10, pp. 595 - 596
CARMENA, a trial comparing the efficacy of sunitinib alone to that of nephrectomy followed by sunitinib in patients with primary metastatic renal cell... 
Kidney Neoplasms - surgery | Carcinoma, Renal Cell - surgery | Sunitinib | Nephrectomy | Cytoreduction Surgical Procedures | Humans | Development and progression | Care and treatment | Kidney cancer | Metastasis | Surgery | Clear cell-type renal cell carcinoma | Metastases
Journal Article
BJU International, ISSN 1464-4096, 12/2012, Volume 110, Issue 11b, pp. E679 - E679
Journal Article
BJU International, ISSN 1464-4096, 12/2012, Volume 110, Issue 11b, p. E679
Journal Article
European Urology, ISSN 0302-2838, 2015, Volume 67, Issue 5, pp. 913 - 924
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 12, pp. e549 - e561
Journal Article
World Journal of Urology, ISSN 0724-4983, 8/2016, Volume 34, Issue 8, pp. 1051 - 1052
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00345-016-1892-5 
Oncology | Nephrology | Medicine & Public Health | Urology | UROLOGY & NEPHROLOGY | Carcinoma, Renal Cell - therapy | Guideline Adherence | Humans | Kidney Neoplasms - therapy | Cancer | Clinical Medicine | Urologi och njurmedicin | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Urology and Nephrology
Journal Article
European Urology, ISSN 0302-2838, 2015, Volume 70, Issue 2, pp. 265 - 280
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 19, pp. 1877 - 1878
Journal Article
Nature Reviews Nephrology, ISSN 1759-5061, 07/2018, Volume 14, Issue 10, pp. 1 - 2
Cytoreductive nephrectomy is the current treatment paradigm for metastatic renal cell carcinoma (RCC). However, the introduction of targeted therapies has... 
SURVIVAL | SUNITINIB | UROLOGY & NEPHROLOGY | CYTOREDUCTIVE NEPHRECTOMY | THERAPY | Kidney Neoplasms - surgery | Carcinoma, Renal Cell | Sunitinib | Nephrectomy | Humans | Treatment outcome | Care and treatment | Usage | Prognosis | Analysis | Carcinoma, Renal cell | Risk factors | Metastasis
Journal Article
Journal Article
World journal of urology, ISSN 0724-4983, 2018, Volume 36, Issue 12, pp. 1973 - 1980
Introduction: Recent trials have emphasized the importance of a precise patient selection for cytoreductive nephrectomy (CN). In 2013, a nomogram was developed... 
Validation | Nephrology | Medicine & Public Health | Targeted therapy | Selection | Nomogram | Metastatic renal cancer | Oncology | Cytoreductive nephrectomy | Urology | THERAPY | PROGNOSTIC-FACTORS | UROLOGY & NEPHROLOGY | CANCER | Adrenal Gland Neoplasms - drug therapy | Lung Neoplasms - drug therapy | Prognosis | Area Under Curve | Humans | Middle Aged | Bone Neoplasms - secondary | Male | Antineoplastic Agents - therapeutic use | Molecular Targeted Therapy | Cytoreduction Surgical Procedures | Patient Selection | Brain Neoplasms - secondary | Neoplasm Metastasis | Blood Transfusion | Lung Neoplasms - secondary | Nephrectomy | Nomograms | Adrenal Gland Neoplasms - secondary | Female | Bone Neoplasms - drug therapy | Liver Neoplasms - secondary | Kidney Neoplasms - therapy | Reproducibility of Results | Carcinoma, Renal Cell - pathology | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Survival Rate | Brain Neoplasms - drug therapy | Kidney Neoplasms - mortality | L-Lactate Dehydrogenase | Carcinoma, Renal Cell - mortality | Serum Albumin | Carcinoma, Renal Cell - secondary | Intraoperative Care | Carcinoma, Renal Cell - therapy | Kidney Neoplasms - pathology | Aged | Neoplasm Staging | Analysis | Metastasis | Carcinoma, Renal cell | Cell survival | Clinical trials | Lactic acid | Patients | Risk factors | Clear cell-type renal cell carcinoma | L-Lactate dehydrogenase | Tumors | Metastases | Clinical Medicine | Urologi och njurmedicin | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | Urology and Nephrology
Journal Article